Cardiovascular Outcomes Inc

“In accordance with its review function, the board of directors shall take the following actions: -select the form 990 preparer. "conduct a detailed review of the form 990 and consider the issues presented. "ensure that the mission statement stated in the form 990 has been approved by the board of directors. "carefully monitor the description of the corporation's purposes and activities reported on the form 990 to ensure accuracy and compliance with section 501(c)(3). "approve and distribute the annual disclosure statement to officers, directors and key employees to acquire information on their respective family and business relationships, transactions with the corporation, potential conflicts of interest, and other information needed to answer various form 990 questions and comply with the corporation's conflicts of interest policy. "consult directly with the form 990 preparer and legal counsel relative to any issues presented on the form.”

“Each covered person will annually sign a statement that affirms such person: "has received a copy of this policy; "has read and understands the policy; "has agreed to comply with the policy; and "understands the corporation is exempt from federal income tax and to maintain its federal tax exemption the corporation must engage primarily in activities that accomplish one or more of its tax-exempt purposes. In addition, each covered person will annually complete, sign and promptly return to the board or the executive committee a questionnaire and disclosure statement substantially in the form attached hereto. A covered person need not disclose compensation paid to the covered person by corporation pursuant to a resolution of the board. Periodic reviews to ensure that the corporation operates in a manner consistent with its tax-exempt purposes and that it does not engage in activities that could jeopardize its status as an organization exempt from federal income tax, the board or the executive committee will conduct periodic reviews. The periodic reviews will, at a minimum, include the following subjects: "if the corporation pays compensation, whether the corporation compensation arrangements are reasonable, based on competent survey information, and are the result of arm's-length bargaining; and "whether transactions and arrangements with other entities and individuals conform to the corporation's policies, are properly recorded, reflect reasonable payments for goods and services, further the corporation's tax-exempt purposes and do not result in private inurement, impermissible private benefit, or in an excess benefit transaction. Use of outside experts when conducting the periodic reviews provided for above, the board or the executive committee should rely on appropriate outside experts when appropriate such as attorneys, appraisers, or compensation or other consultants.”

“The organization does not compensate its top officer's.”

“1. Services to be provided must be specified and approved by a board member, including a maximum reimbursement amount. 2. Once services are approved, a summary of work provided, direct expenses and any consultation fees must accompany an invoice prior to any payment being issued. Consultation fees will require documentation of hours spent or services performed and will be provided at the consultant's usual and customary fee. These will be approved by a board member as being reasonable for the services provided. 3. If services are provided without a formal, signed agreement, then payment amount will be determined by the officer or board member, as if the request had been made prior to the completion of the work. If approval is not provided, then no payments will be made. An invoice is required prior to any payment being issued.”

“On the company's website "www.cvoutcomes.org" there is a statement stating "policies related to the goverance of cv outcomes, inc. Are available upon request." when you click on the statement, it will link to an e-mail address were people can request the information they want.”

“The approach for the project was developed in conjunction with yale-new haven hospital ("ynhh"), a section 501(c)(3) hospital. The organization, pursuant to its agreement with me2health, worked collaboratively with ynhh to develop the research project. This epic-based health system is one of the largest in the country and contains the nation's 5th largest hospital. They have more than 110,000 discharges per year and more than 1.6 million outpatient encounters. The approach was to use yale-new haven hospital as a laboratory to overcome the challenges of sending digital health data securely from the hospital systems to an independent, cloud-based system that allows an individual to have control over their own data and share it if they wish. This is a proof of concept project that has implications for clinical care and research. The preliminary tools developed by the organization through the me2health agreement also were used by yale in collaboration with the organization for other research projects. One proposal was the yale participant technologies center (yptc) that was led by yale university and in partnership with university of california san francisco, university of chicago, me2health, the national partnership of women and families and accenture. This was designed to support the precision medicine initiative (pmi) by enabling people to become authentic partners with researchers to produce research databases that can contribute to scientific breakthroughs and be personalized to each individual. The grant application for the project states that the yptc will develop, test, maintain and upgrade the pmi platform to support enrollment, consent, data collection, communication, and feedback; provide parallel systems for participants without cell phones; collaborate with technology entities to increase smartphone accessibility; obtain passive sensor technologies for selected participants; extract meaningful and interoperable data from current technologies; and assist the pmi coordinating center in data acquisition and management from participant technologies. A second project using the preliminary me2health product was with the yale clinical and translational science awards (ctsa). The research focused on conducting patient-centered research developed in partnership with ynhh. A product was developed that is free to patients, auto-populated from electronic health records.”

“Premier: publishing from the premier registry (prospective registry evaluating outcomes after myocardial infarction: events and recovery) remains a large part of cvo's accomplishments. The extensive database continues to be used by multiple investigators, physicians and nurses alike, for several publications this year.”